𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Prognostic factors for survival in metastatic renal cell carcinoma : Update 2008

✍ Scribed by Ronald M. Bukowski


Publisher
John Wiley and Sons
Year
2009
Tongue
English
Weight
270 KB
Volume
115
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Prognostic factors for survival in patie
✍ StΓ©phane Culine; Mohamed Bekradda; Andrew Kramar; Annie Rey; Bernard Escudier; J πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 77 KB πŸ‘ 3 views

The authors thank S. Ne Β΄grier, M.D., A. Ravaud, M.D., and G. Chvetzoff for providing the clinical charts of patients included in the external data set.

Prognostic nomogram for sunitinib in pat
✍ Robert J. Motzer; Ronald M. Bukowski; Robert A. Figlin; Thomas E. Hutson; M. Dro πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 115 KB πŸ‘ 2 views

## Abstract ## BACKGROUND. In a randomized, phase 3 trial, sunitinib demonstrated superior efficacy over interferon‐alfa as first‐line therapy in patients with metastatic clear‐cell renal cell carcinoma (RCC). On the basis of outcome data from that trial, the authors developed a nomogram for predi

Future prognostic factors for renal cell
✍ David A. Swanson; Harold J. Rothenberg; Alton L. Boynton; David Consigliere; Kev πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 English βš– 34 KB πŸ‘ 2 views

cause they may be impractical, expensive, or unproven. Group II is an intermediate group expected to be available in the near future and Presented at ''Diagnosis and Prognosis of Renal characterized by greater requirements for time, money, and other Cell Carcinoma: 1997 Workshop,'' Rochester, resour